CBAV — Clinica Baviera SA Cashflow Statement
0.000.00%
Last trade - 00:00- €668.52m
- €638.30m
- €262.65m
- 99
- 44
- 74
- 89
Annual cashflow statement for Clinica Baviera SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 20.2 | 38.9 | 40.7 | 49.7 | 56 |
| Depreciation | |||||
| Non-Cash Items | -0.317 | 1.31 | 2.36 | 1.06 | 0.521 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.96 | -7.44 | -4.66 | -9.89 | -14.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 31.5 | 46.9 | 53.4 | 57.8 | 62.5 |
| Capital Expenditures | -7.82 | -10.6 | -14 | -22.7 | -26.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -13.6 | -6.51 | 1.47 | -21.6 | 5.61 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -21.4 | -17.1 | -12.6 | -44.3 | -20.9 |
| Financing Cash Flow Items | -0.269 | -0.113 | -0.551 | -0.28 | -0.363 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.15 | -30.8 | -31.4 | -24.4 | -39.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.9 | -1.02 | 9.37 | -10.9 | 1.83 |